In comparison, approximately 70%–80% and 32%–75% of newly diagnosed T1D patients without APECED have detectable circulating GAD65 and IA-2 autoantibodies, respectively [27]. This evidence concerns the gene GAD2 and type 1 diabetes mellitus.